An Impermeant Ganetespib Analog Inhibits Extracellular Hsp90-Mediated Cancer Cell Migration that Involves Lysyl Oxidase 2-like Protein.
Extracellular Hsp90 (eHsp90) activates a number of client proteins outside of cancer cells required for migration and invasion. Therefore, eHsp90 may serve as a novel target for anti-metastatic drugs as its inhibition using impermeant Hsp90 inhibitors would not affect the numerous vital intracellular Hsp90 functions in normal cells. While some eHsp90 clients are known, it is important to establish other proteins that act outside the cell to validate eHsp90 as a drug target to limit cancer spread. Using mass spectrometry we identified two precursor proteins Galectin 3 binding protein (G3BP) and Lysyl oxidase 2-like protein (LOXL2) that associate with eHsp90 in MDA-MB231 breast cancer cell conditioned media and confirmed that LOXL2 binds to eHsp90 in immunoprecipitates. We introduce a novel impermeant Hsp90 inhibitor STA-12-7191 derived from ganetespib and show that it is markedly less toxic to cells and can inhibit cancer cell migration in a dose dependent manner. We used STA-12-7191 to test if LOXL2 and G3BP are potential eHsp90 clients. We showed that while LOXL2 can increase wound healing and compensate for STA-12-7191-mediated inhibition of wound closure, addition of G3BP had no affect on this assay. These findings support of role for LOXL2 in eHsp90 stimulated cancer cell migration and provide preliminary evidence for the use of STA-12-7191 to inhibit eHsp90 to limit cancer invasion.
Department of Natural Sciences, Assumption College, Worcester, MA 01609, USA. j.mccready@assumption.edu.
Jessica
J
McCready
Department of Developmental Molecular and Chemical Biology, Tufts University School of Medicine, Boston, MA 02111, USA. daniel_s.wong@tufts.edu.
Daniel S
DS
Wong
Synta Pharmaceuticals, Lexington, MA 02421, USA. joeburlison@gmail.com.
Joseph A
JA
Burlison
Synta Pharmaceuticals, Lexington, MA 02421, USA. wying@syntapharma.com.
Weiwen
W
Ying
Department of Developmental Molecular and Chemical Biology, Tufts University School of Medicine, Boston, MA 02111, USA. daniel_s.wong@tufts.edu.
Daniel G
DG
Jay